InvestorsHub Logo
Followers 5
Posts 1418
Boards Moderated 0
Alias Born 11/10/2015

Re: mcsharkey post# 41415

Saturday, 09/24/2016 8:20:15 AM

Saturday, September 24, 2016 8:20:15 AM

Post# of 58837
a change of focus...let´s briefly talk a bit about Art, because nobody ever does...And to hear some of your takes on this...so please let me know what you think....
I mentioned before I suspect lots of fine artwork allready tagged in US warehouses and believe Aris Title, backing up i2M standards program in co-op with University of Albany to be moving from pilot to bigger commersialisation any time now...

Didn´t Hayward mention Art as one of the verticals most plausable to generate revs not to long from now? Where is it these days...can´t find Art anymore on our website? Did we lose some patentbattles? What do we know? We know of involvement of University of Albany which has clear ties with adnas/Stoneybrook, about Provenire Authentications the apparent manufacturer of this synthetic dna and Rensselaer with Chung Researchis supposed to be contributing as well.

Is this some sister tech or development under apdn license? Wouldn´t apdn be behind it when they explicitly stated Art as a nearterm revenuedriver back in august 2015? Wouldn´t it be our battletested dna that was to endure all different physical abuse you would get from artproductiontechniques? Wouldnt ours be the dna to be able to embed in all kinds of material? Wouldnt it be our tracknTrace platform that is militarygrade, as mentioned somewhere in on of the Media Articles?

Some more info:

Aris Title explaining

"Independant dna manufacturer"

A list of newsarticle mainly 2nd half of 2015

Been digging around before, but can´t see to make a complete picture. What do you guys think?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News